ImmunOs Therapeutics AG

London-based vaccine company Vicebio Ltd. has become the 17th company this year to raise a nine-figure series B round, according to Evaluate data. TCGX led its $100m series B venture capital round,

The number of biopharmaceutical companies raising venture capital this year has far outpaced the number raising money in public offerings, with 126 venture rounds during the first quarter versus just

As new treatments go under the spotlight at the American Society of Clinical Oncology meeting in Chicago, ImmunOs Therapeutics AG has concluded a healthy financing round to help advance its new clas